– USA, CA – Eargo, a US-based medical device company, has raised $71m in an equity financing round led by new co-investors Gilde Healthcare and Longitude Capital joined by the existing investors New Enterprise Associates, the Charles and Helen Schwab Foundation and Nan Fung Life Sciences.…
– SWITZERLAND, Lausanne – Polares Medical SA, a clinical-stage medical technology company focused on the development of a unique trans-catheter mitral valve hemi-replacement system to treat patients suffering from mitral regurgitation, today announced the closing of a $40 million financing led by Longitude Capital with the participation of Decheng Capital, Endeavour Vision, IDO Investments, Earlybird Venture Capital, and Wellington Partners.…
– USA, MN – Amphora Medical, Inc., a developer of medical devices to treat overactive bladder (OAB), today announced the closing of a $35.5 million Series B financing.…
– USA, CA – Tricida, Inc., a privately-held, clinical stage, biopharmaceutical company focused on the discovery and development of first-in-class chronic therapies for patients with chronic kidney disease, announced today that it has raised a $55M Series C round, bringing the company’s total financing to $95M.…
– USA, MA – Kala Pharmaceuticals, Inc. (Kala), a developer of innovative ophthalmic products based on its proprietary mucus-penetrating particle (MPP) technology, announced that it has closed a highly oversubscribed $68 million Series C preferred stock financing, led by Longitude Capital.…